Professor Roger Seheult, MD explains new data from large trials that demonstrate full dose anticoagulants may improve outcomes for patients hospitalized with COVID 19. This is important news because we’ve learned over the past year that thromboembolic (blood clot) complications from COVID-19 contribute significantly to morbidity (pulmonary embolism, stroke, myocardial infarction, etc.) and mortality (This video was recorded on January 24, 2021).
Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.
Lämna ett svar